[Federal Register: July 25, 2002 (Volume 67, Number 143)]
[&thnsp;Notices]               
[Page 48665]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25jy02-77]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Food Biotechnology Subcommittee of the Food Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Food Biotechnology Subcommittee of the Food 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on August 13, 2002, from 9 
a.m. to 4:30 p.m. and August 14, 2002, from 9 a.m. to 4:30 p.m.
    Location: Harvey W. Wiley Federal Bldg., 5100 Paint Branch Pkwy., 
College Park, MD 20740, 301–436–2200.
    Contact Person: Margaret E. Cole, Center for Food Safety and 
Applied Nutrition (HFS–006), Food and Drug Administration, 5100 
Paint Branch Pkwy., College Park, MD 20740, 301–436–2397, 
or FDA Advisory Committee Information Line, 
1–800–741–8138 (301–443–0572 in the 
Washington, DC area), code 10564. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The purpose of the meeting is to discuss science-based 
approaches to assessing whether new proteins in bioengineered foods are 
likely to cause allergic reactions in some individuals in order to 
assist FDA in developing a draft guidance for industry.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by July 30, 2002. 
Oral presentations from the public will be scheduled between 
approximately 10:15 a.m. and 11:30 a.m. on August 14, 2002. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before July 
30, 2002, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Margaret E. Cole at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: July 18, 2002.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 02–18773 Filed 7–24–02; 8:45 am]
BILLING CODE 4160–01–S